JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying registrant · 46038

139 filings on record; a reported $2,385,000 in total across them. Honesty note: each amount is the registrant's reported lobbying income/spend for that quarter (a lump sum required by the Lobbying Disclosure Act, or LDA — the law governing public lobbying reports), so this total is a gross sum of quarterly figures. The filings do disclose which bills were lobbied on (below), but never how much of the money went to any one bill, and never whether the filer supported or opposed it.

Clients

Filings

ClientPeriodReported quarterly amountFiling type
COALITION FOR AFFORDABLE PET CARE Q2 2026 $20,000 Q2
NEURALINK CORP. Q2 2026 $60,000 Q2
MANNKIND CORPORATION Q2 2026 $10,000 Q2
GAURDANT HEALTH Q2 2026 $10,000 Q2
ATARA BIOTHERAPEUTICS, INC. Q2 2026 $10,000 Q2
INDEMED Q2 2026 $10,000 Q2
MAGNOLIA MEDICAL TECHNOLOGIES, INC. Q2 2026 $10,000 Q2
MAGNUS MEDICAL, INC. Q2 2026 $10,000 Q2
COLOPLAST CORP Q2 2026 $10,000 Q2
RAYNER INTRAOCULAR LENSES LIMITED Q2 2026 $15,000 Q2
ORCHARD THERAPEUTICS NORTH AMERICA Q2 2026 $10,000 Q2
SKY MARKETING CORPORATION Q2 2026 $20,000 Q2
PAR HEALTH USA, LLC Q2 2026 $15,000 Q2
INDIVIOR INC. Q2 2026 $10,000 Q2
ASTELLAS PHARMA US Q2 2026 $40,000 Q2
AGIOS PHARMACEUTICALS, INC. Q2 2026 $10,000 Q2
NEUSPERA MEDICAL Q2 2026 $10,000 Q2
MOBIA MEDICAL, INC (FKA MICROTRANSPONDER) Q2 2026 $10,000 Q2
GENETIX BIOTHERAPEUTICS Q2 2026 $15,000 Q2
OPUS GENETICS, INC Q2 2026 $15,000 Q2
ATEA PHARMACEUTICALS, INC. Q2 2026 $10,000 Q2
ACME UNITED CORPORATION Q2 2026 $10,000 Q2
AVALON HEALTHCARE SOLUTIONS Q2 2026 $10,000 Q2
THE ALLERGY & ASTHMA ALLIANCE Q2 2026 $20,000 Q2
CAPRICOR Q2 2026 $10,000 Q2
ONE CALL, CORP Q2 2026 $15,000 Q2
INNOVAGE Q2 2026 $20,000 Q2
PHATHOM PHARMACEUTICALS Q2 2026 $15,000 Q2
RECOR MEDICAL Q2 2026 $20,000 Q2
SUMMIT BEHAVIORAL HEALTHCARE Q2 2026 $15,000 Q2
ALEXION PHARMACEUTICALS Q2 2026 $10,000 Q2
INSMED, INC. Q2 2026 $10,000 Q2
HARROW INC. Q2 2026 $20,000 Q2
KENDAL NUTRICARE LTD Q2 2026 $20,000 Q2
BIOTISSUE Q2 2026 $9,000 Q2
SPARC Q2 2026 $15,000 Q2
NEUROTECH PHARMACEUTICALS Q2 2026 $10,000 Q2
AMGEN INC. Q2 2026 $7,500 Q2
ILLUMINA, INC. Q2 2026 $18,750 Q2
WE WORK FOR HEALTH Q2 2026 $30,000 Q2
MOMENTOUS Q2 2026 $15,000 Q2
COLLEGIUM PHARMACEUTICAL Q2 2026 $10,000 Q2
PHARMING HEALTHCARE, INC. Q2 2026 $10,000 Q2
SUPERNUS PHARMACEUTICALS INC Q2 2026 $20,000 Q2
MEDICAL DEVICE MANUFACTURERS ASSOCIATION Q2 2026 $10,000 Q2
ORGANON & CO. Q2 2026 $5,000 Q2
STERIS CORPORATION Q2 2026 $20,000 Q2
INSTITUTE FOR GENE THERAPIES Q2 2026 $20,000 Q2
GILEAD SCIENCES, INC. Q2 2026 $75,000 Q2
BROOKDALE SENIOR LIVING INC. Q2 2026 $40,000 Q2
CATALYST PHARMACEUTICALS Q2 2026 $30,000 Q2
HARMONY BIOSCIENCES, LLC Q2 2026 $20,000 Q2
ARDELYX, INC. Q2 2026 $40,000 Q2
GENUS LIFESCIENCES Q2 2026 $36,000 Q2
TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION (FKN TENNESSEE FARM BR. ASSN.) Q2 2026 $30,000 Q2
U.S. RENAL CARE Q2 2026 $50,000 Q2
ACCURAY INCORPORATED Q2 2026 $40,000 Q2
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. Q2 2026 $40,000 Q2
GLAUKOS CORPORATION (FKA AVEDRO, INC.) Q2 2026 $20,000 Q2
TERUMO BCT Q2 2026 $20,000 Q2
SSI GROUP Q2 2026 $20,000 Q2
LIVANOVA USA INC Q2 2026 $30,000 Q2
COALITION FOR AFFORDABLE PET CARE Q2 2026 not reported RR
GALVANIZE THERAPEUTICS, INC. Q2 2026 not reported 2TY
NEURALINK CORP. Q2 2026 not reported RR
MANNKIND CORPORATION Q2 2026 not reported RR
THE ALLERGY, ASTHMA & SINUS CENTER Q2 2026 $20,000 2T
GAURDANT HEALTH Q2 2026 not reported RR
ATARA BIOTHERAPEUTICS, INC. Q2 2026 not reported RR
INDEMED Q2 2026 not reported RR
MAGNOLIA MEDICAL TECHNOLOGIES, INC. Q2 2026 not reported RR
MAGNUS MEDICAL, INC. Q2 2026 not reported RR
GALVANIZE THERAPEUTICS, INC. Q1 2026 $15,000 Q1
WE WORK FOR HEALTH Q1 2026 $30,000 Q1
INSTITUTE FOR GENE THERAPIES Q1 2026 $20,000 Q1
RECOR MEDICAL Q1 2026 $20,000 Q1
NEUSPERA MEDICAL Q1 2026 $10,000 Q1
STERIS CORPORATION Q1 2026 $20,000 Q1
LIVANOVA USA INC Q1 2026 $30,000 Q1
GLAUKOS CORPORATION (FKA AVEDRO, INC.) Q1 2026 $20,000 Q1
RAYNER INTRAOCULAR LENSES LIMITED Q1 2026 $15,000 Q1
INNOVAGE Q1 2026 $20,000 Q1
HARROW INC. Q1 2026 $20,000 Q1
COLOPLAST CORP Q1 2026 $10,000 Q1
BIOTISSUE Q1 2026 $9,000 Q1
PHARMING HEALTHCARE, INC. Q1 2026 $10,000 Q1
PHATHOM PHARMACEUTICALS Q1 2026 $15,000 Q1
MOBIA MEDICAL, INC (FKA MICROTRANSPONDER) Q1 2026 $10,000 Q1
ATEA PHARMACEUTICALS, INC. Q1 2026 $10,000 Q1
ACME UNITED CORPORATION Q1 2026 $10,000 Q1
AGIOS PHARMACEUTICALS, INC. Q1 2026 $10,000 Q1
KENDAL NUTRICARE LTD Q1 2026 $10,000 Q1
CATALYST PHARMACEUTICALS Q1 2026 $30,000 Q1
SKY MARKETING CORPORATION Q1 2026 $20,000 Q1
SSI GROUP Q1 2026 $20,000 Q1
ONE CALL, CORP Q1 2026 $10,000 Q1
AVALON HEALTHCARE SOLUTIONS Q1 2026 $10,000 Q1
INSMED, INC. Q1 2026 $10,000 Q1
ILLUMINA, INC. Q1 2026 $18,750 Q1
HARMONY BIOSCIENCES, LLC Q1 2026 $20,000 Q1
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. Q1 2026 $40,000 Q1
SUPERNUS PHARMACEUTICALS INC Q1 2026 $20,000 Q1
SCPHARMACEUTICALS, INC. Q1 2026 $12,500 1T
ORGANON & CO. Q1 2026 $5,000 Q1
ALEXION PHARMACEUTICALS Q1 2026 $10,000 Q1
GILEAD SCIENCES, INC. Q1 2026 $75,000 Q1
PAR HEALTH USA, LLC Q1 2026 $15,000 Q1
ORCHARD THERAPEUTICS NORTH AMERICA Q1 2026 $10,000 Q1
OPUS GENETICS, INC Q1 2026 $15,000 Q1
TERUMO BCT Q1 2026 $20,000 Q1
ARDELYX, INC. Q1 2026 $40,000 Q1
ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY Q1 2026 not reported 1TY
CAPRICOR Q1 2026 $10,000 Q1
GENETIX BIOTHERAPEUTICS Q1 2026 $15,000 Q1
MOMENTOUS Q1 2026 $15,000 Q1
ASTELLAS PHARMA US Q1 2026 $40,000 Q1
MAGNUS MEDICAL, INC. Q1 2026 not reported Q1Y
NEUROTECH PHARMACEUTICALS Q1 2026 $10,000 Q1
U.S. RENAL CARE Q1 2026 $50,000 Q1
ACCURAY INCORPORATED Q1 2026 $40,000 Q1
INDIVIOR INC. Q1 2026 $10,000 Q1
GENUS LIFESCIENCES Q1 2026 $36,000 Q1
BROOKDALE SENIOR LIVING INC. Q1 2026 $40,000 Q1
MEDICAL DEVICE MANUFACTURERS ASSOCIATION Q1 2026 $10,000 Q1
THE ALLERGY & ASTHMA ALLIANCE Q1 2026 $20,000 Q1
SPARC Q1 2026 $15,000 Q1
AMGEN INC. Q1 2026 $7,500 Q1
COLLEGIUM PHARMACEUTICAL Q1 2026 $10,000 Q1
TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION (FKN TENNESSEE FARM BR. ASSN.) Q1 2026 $30,000 Q1
SUMMIT BEHAVIORAL HEALTHCARE Q1 2026 $15,000 Q1
THE ALLERGY, ASTHMA & SINUS CENTER Q1 2026 $20,000 Q1
AVITA MEDICAL, INC. Q1 2026 $15,000 1T
MEDICARE ALLIANCE FOR BENEFICIARY ACCESS, INC. Q1 2026 not reported 1TY
CUBBY BEDS Q1 2026 $10,000 1T
AXOGEN CORPORATION Q1 2026 $15,000 1T
RAYNER INTRAOCULAR LENSES LIMITED Q1 2026 not reported RR
COLOPLAST CORP Q1 2026 not reported RR
ORCHARD THERAPEUTICS NORTH AMERICA Q1 2026 not reported RR
SKY MARKETING CORPORATION Q1 2026 not reported RR

Source: Senate LDA filings.

Bills lobbied on

Bills named in this registrant's filings. A titled link means the bill is in our corpus; a bare canonical reference means it is not.

Bill references are free-text extractions from LDA specific_issues; they show a bill was named in a quarter, not money spent on it.

Lobbying ≠ campaign money. These LDA lobbying figures are a separate, unbridged channel from FEC campaign contributions; this platform does not yet link a lobbying registrant to any FEC committee. See the methodology glossary.